| The effect of short-chain fatty acids on human monocyte-derived dendritic cells C Nastasi, M Candela, CM Bonefeld, C Geisler, M Hansen, T Krejsgaard, ... Scientific reports 5 (1), 16148, 2015 | 363 | 2015 |
| Predictors of responses to immune checkpoint blockade in advanced melanoma N Jacquelot, MP Roberti, DP Enot, S Rusakiewicz, N Ternès, S Jegou, ... Nature communications 8 (1), 592, 2017 | 189 | 2017 |
| Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells C Nastasi, S Fredholm, A Willerslev-Olsen, M Hansen, CM Bonefeld, ... Scientific reports 7 (1), 14516, 2017 | 86 | 2017 |
| The role of dendritic cells in cancer M Hansen, MH Andersen Seminars in immunopathology 39, 307-316, 2017 | 85 | 2017 |
| Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma R Andersen, M Donia, MCW Westergaard, M Pedersen, M Hansen, ... Human vaccines & immunotherapeutics 11 (12), 2790-2795, 2015 | 79 | 2015 |
| CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment E Martinenaite, S Munir Ahmad, M Hansen, Ö Met, MW Westergaard, ... Oncoimmunology 5 (11), e1238541, 2016 | 74 | 2016 |
| Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study P Kongsted, TH Borch, E Ellebaek, TZ Iversen, R Andersen, Ö Met, ... Cytotherapy 19 (4), 500-513, 2017 | 70 | 2017 |
| In-chip fabrication of free-form 3D constructs for directed cell migration analysis MH Olsen, GM Hjortø, M Hansen, Ö Met, IM Svane, NB Larsen Lab on a Chip 13 (24), 4800-4809, 2013 | 69 | 2013 |
| Differential CCR7 targeting in dendritic cells by three naturally occurring CC-chemokines GM Hjortø, O Larsen, A Steen, V Daugvilaite, C Berg, S Fares, M Hansen, ... Frontiers in Immunology 7, 218657, 2016 | 67 | 2016 |
| Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients C Jensen, DH Madsen, M Hansen, H Schmidt, IM Svane, MA Karsdal, ... Journal for Immunotherapy of Cancer 6, 1-10, 2018 | 64 | 2018 |
| Expansion of circulating CD56bright natural killer cells in patients with JAK2‐positive chronic myeloproliferative neoplasms during treatment with interferon‐α CH Riley, M Hansen, MK Brimnes, H Hans C., OW Bjerrum, P Straten, ... European Journal of Haematology, 2014 | 55 | 2014 |
| Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion M Donia, M Hansen, SL Sendrup, TZ Iversen, E Ellebæk, MH Andersen, ... Journal of Investigative Dermatology, 2012 | 54 | 2012 |
| Injection molded chips with integrated conducting polymer electrodes for electroporation of cells KØ Andresen, M Hansen, M Matschuk, ST Jepsen, HS Sørensen, P Utko, ... Journal of Micromechanics and Microengineering 20, 055010, 2010 | 51 | 2010 |
| Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy M Hansen, GM Hjortø, M Donia, Ö Met, NB Larsen, MH Andersen, ... Vaccine 31 (4), 639-646, 2013 | 44 | 2013 |
| PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine S Munir Ahmad, E Martinenaite, M Hansen, N Junker, TH Borch, Ö Met, ... Oncoimmunology 5 (8), e1202391, 2016 | 41 | 2016 |
| Cellular Based Cancer Vaccines: Type 1 Polarization of Dendritic Cells M Hansen, O Met, IM Svane, MH Andersen Current Medicinal Chemistry 19 (25), 4239-4246, 2012 | 41 | 2012 |
| mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma TH Borch, L Engell-Noerregaard, T Zeeberg Iversen, E Ellebaek, Ö Met, ... Oncoimmunology 5 (9), e1207842, 2016 | 36 | 2016 |
| Granzyme B degraded type IV collagen products in serum identify melanoma patients responding to immune checkpoint blockade C Jensen, D Sinkeviciute, DH Madsen, P Önnerfjord, M Hansen, ... Cancers 12 (10), 2786, 2020 | 34 | 2020 |
| Interferon‐α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK 2V617F‐positive essential thrombocythemia … CH Riley, MK Brimnes, M Hansen, MK Jensen, HC Hasselbalch, L Kjaer, ... European Journal of Haematology 97 (1), 83-92, 2016 | 34 | 2016 |
| Therapeutic cancer vaccination with a peptide derived from the calreticulin exon 9 mutations induces strong cellular immune responses in patients with CALR-mutant chronic … J Handlos Grauslund, MO Holmström, NG Jørgensen, U Klausen, ... Frontiers in oncology 11, 637420, 2021 | 33 | 2021 |
Marco DoniaDr.Email confirmado em regionh.dk
